Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $59.52 USD
Change Today +2.02 / 3.51%
Volume 885.2K
LCI On Other Exchanges
New York
As of 8:04 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martin P. Galvan CPA

Chief Financial Officer, Vice President of Finance and Treasurer, Lannett Company, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2014


Mr. Martin P. Galvan, also known as Marty, CPA has been the Chief Financial Officer, Vice President of Finance and Treasurer at Lannett Company, Inc. since August 8, 2011. Mr. Galvan joind Lannett with more than 25 years of senior financial management expertise in the life sciences industry. He served as the Chief Financial Officer of CardioNet Inc. from September 2007 to January 15, 2010 and as its Chief Operating Officer of PDSHeart since October 2007. He also served ...

Read Full Background

Corporate Headquarters*

9000 State Road
Philadelphia, Pennsylvania 19136

United States

Phone: 215-333-9000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


Bachelor's Degree
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Total Annual Compensation$317,000

Stock Options*

Restricted Stock Awards$637,450
All Other Compensation$20,645
Exercisable Options37,332
Exercisable Options Value$1,681,913
Unexercisable Options84,668
Unexercisable Options Value$3,356,407
Total Value of Options$5,038,320
Total Number of Options122,000

Total Compensation*

Total Annual Cash Compensation$718,045
Total Short Term Compensation$317,000
Other Long Term Compensation$658,095
Total Calculated Compensation$1,759,287
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LCI:US $59.52 USD +2.02


George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Samuel M. Inman IIIChairman, Chief Executive Officer and President
Covisint Corporation
Dhananjaya Alii Managing Director and Executive Director
Vista Pharmaceuticals Limited
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANNETT CO INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at